I am eager to understand what management was doing between January and June while waiting for the approval to fix instruction errors. That certainly wasn't six months' worth of effort. They had promised to address multiple issues immediately after FDA approval and swiftly move forward with marketing and sales launch next steps. What progress has been made with insurers and health service providers? Where do we stand with contracted PBMs? Enough with the fluff.
The CR is resolved, the FDA approval is in place. It's time to reward your loyal long-term holders with constant updates instead of waiting for a potential disaster with your quarterly report in September/October.
Angry frustrated but patient long-term BOT holder
BOT - Anything but charting, page-8989
-
- There are more pages in this discussion • 1,182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.015(3.75%) |
Mkt cap ! $751.1M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.8¢ | 39.3¢ | $5.876M | 14.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 252500 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 78414 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |